<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04370925</url>
  </required_header>
  <id_info>
    <org_study_id>HIPEC-06</org_study_id>
    <nct_id>NCT04370925</nct_id>
  </id_info>
  <brief_title>Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis</brief_title>
  <official_title>A Multicenter Prospective Randomized Controlled Clinical Trial of Hyperthermic Intraperitoneal Chemotherapy After Colectomy in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Affiliated Cancer Hospital &amp; Institute of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Provincial Hospital of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guangdong Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Meizhou People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People's Hospital of Foshan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shantou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jiangmen Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shenzhen Second People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Zhongshan People's Hospital, Guangdong, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ZhuHai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cancer Institute and Hospital, Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chongqing University Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Renmin Hospital of Wuhan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sichuan Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The People's Hospital of Leshan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People’s Hospital of Deyang City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hebei Medical University Fourth Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Nanchang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital Of Southwest Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Hospital of Xuzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>People's Hospital of Guangxi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Third People's Hospital of Chengdu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Tumor Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Affiliated Cancer Hospital &amp; Institute of Guangzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of adjuvant HIPEC with Mitomycin C
      after colectomy in the treatment of colorectal cancer patients at high risk of peritoneal
      carcinomatosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The effectiveness of cytoreductive surgery combined with hyperthermic intraperitoneal
      chemotherapy (HIPEC) have been addressed for the treatment of peritoneal carcinomatosis in
      selected patients. However, prophylactic HIPEC in colorectal cancer patients at high risk of
      metachronous peritoneal metastases remained controversial. In this study, patients with
      colorectal cancer cT4N0-2M0(AJCC/UICC staging system 8th edition) and planed to undergo
      intentionally colectomy (laparotomy, laparoscopy，or robotic ) are randomized into HIPEC group
      and control group. In HIPEC group, closed HIPEC is performed with Mitomycin C(30mg/m2) at 43
      °C for 90 minutes, simultaneously or within 2 days after colectomy and followed by systemic
      chemotherapy. For the patients in the control group, systemic chemotherapy were administered
      after colectomy. The primary endpoint is peritoneal recurrence-free survival (pRFS) rate.
      Secondary end points include overall survival (OS) rate, disease free survival (DFS) rate,
      liver metastatic rate, toxic effects, quality of life scores. All efficacy analyses are
      conducted in the intention-to-treat population, per-protocol population and pT4 subgroups due
      to pathologic tumor invasion can not be acquired before HIPEC. Safety analysis include only
      patients who receive their randomly assigned treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2020</start_date>
  <completion_date type="Anticipated">April 30, 2026</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peritoneal recurrence free survival</measure>
    <time_frame>3-year</time_frame>
    <description>Peritoneal recurrence free survival is calculated from the date of randomization to the date of record peritoneal recurrence(with or without other metastasis), ovarian metastasis, malignant ascites, or death from any cause, whichever occurred first.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>3-year</time_frame>
    <description>Disease free survival is calculated from randomization to to the date of a first relapse, the diagnosis of a secondary colorectal cancer after the initial diagnosis, or death from any cause, whichever occurred first.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>5-year</time_frame>
    <description>Overall survival is calculated from randomization to death from any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver metastatic rate</measure>
    <time_frame>3-year</time_frame>
    <description>Liver metastatic rate is calculated from randomization to to the date of liver metastasis with or without other organ metastasis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>Up to 1 month after the last chemotherapy cycle</time_frame>
    <description>Incidence of acute and late toxicity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">688</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Matched control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients undergo radical resection of primary colorectal cancer and receive standard adjuvant systemic chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIPEC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo radical resection of colorectal cancer and HIPEC simultaneously or within 2 days after primary tumor resection. Followed by standard adjuvant systemic chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radical colectomy</intervention_name>
    <description>Patients undergo radical resection of the primary colorectal cancer(open or laparoscopic/robotic)</description>
    <arm_group_label>HIPEC</arm_group_label>
    <arm_group_label>Matched control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HIPEC</intervention_name>
    <description>HIPEC(simultaneously or within 2days after resection) with mitomycin c (30 mg/m2) at 43°C for 90 minutes.</description>
    <arm_group_label>HIPEC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Systemic chemotherapy</intervention_name>
    <description>Systemic chemotherapy regimens: CapeOx and mFOLFOX6 are preferred for stage Ⅲ patients.
CapeOx:oxaliplatin 130 mg/m2 IV d1 + capecitabine 1000mg/m2 po bid d1-14. Repeat every three weeks for eight cycles.
mFOLFOX6:oxaliplatin 85 mg/m2 IV d1 + leucovorin calcium 400 mg/m2 IV d1 + 5-FU 400 mg/m2 IV bolus d1 + 5-FU 2400 mg/m2 continuous IV over 46-48 hours d1-2. Repeat every two weeks for twelve cycles.
For stageⅡpatiens, regimens recommend by NCCN guide line(2019 v1) are acceptable.</description>
    <arm_group_label>HIPEC</arm_group_label>
    <arm_group_label>Matched control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 70 years

          -  Nonpregnant or breast-feeding women

          -  ECOG status 0-1

          -  Colorectal adenocarcinoma or mucinous adenocarcinoma;

          -  Intraoperative confirmed cT4N0-2M0 Colorectal cancer (visual determination - according
             to AJCC 8th edition) without previous anti-cancer treatment and R0 resection could be
             achieved

          -  Laboratory tests within 2 weeks before Randomization：Neutrophil ≥ 2.0 /mm3, ,
             platelets ≥ 100,000/mm3, hemoglobin≥90g/l, Alanine transaminase (ALT) and aspartate
             aminotransferase (AST) ≤ 2.5 ×ULN), total bilirubin(TBIL)≤ 1.5 × ULN, serum creatinine
             ≤ 1.5 ×ULN

          -  Written informed consent

        Exclusion Criteria:

          -  Rectal cancer below peritoneal reflection

          -  Concurrent with or have other cancer within the past 5 years ( except for skin basal
             cell carcinoma, or cervical carcinoma in situ, who have received radical treatment)

          -  Severe abdominal infection or extensive fibrosis of peritoneal cavity that lead to
             impossible separation

          -  Surgical procedures conversion(from robotic or laparoscopic surgery to laparotomy) or
             emergency surgery due to perforation or obstruction

          -  Existence of distance metastasis during surgery (M1) or can not achieve R0 resection

          -  Contraindiction of mitomycin c(chickenpox or shingles)

          -  Poorly controlled respiratory or cardiac disease, severe hepatic or renal
             dysfunction,drug abuse or uncontrolled mental disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shuzhong Cui, MD</last_name>
    <phone>086-13802513800</phone>
    <email>cuishuzhong@gzhmu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tianpei Guan, MD</last_name>
    <phone>086-13660895051</phone>
    <email>dr_guan@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bin Liang, MD</last_name>
      <phone>0086-136-8144-4694</phone>
      <email>13681444694@163.com</email>
    </contact>
    <investigator>
      <last_name>Bin Liang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chao Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gang Zhao, MM</last_name>
      <phone>13910714396</phone>
      <email>njg656@163.com</email>
    </contact>
    <investigator>
      <last_name>Gang Zhao, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hua Yang, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cancer Hospital Chinese Academy of Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xishan Wang, MD</last_name>
      <phone>086-13552367779</phone>
      <email>Wxshan1208@126.com</email>
    </contact>
    <investigator>
      <last_name>Xishan Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Pei, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Peking University Cancer Hospital &amp; Institute</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aiwen Wu, MD</last_name>
      <phone>086-13911577190</phone>
      <email>wuaw@sina.com</email>
    </contact>
    <investigator>
      <last_name>Qiushi Dong, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aiwen Wu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chongqing Cancer Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hao Sun, MD</last_name>
      <phone>086-13508370438</phone>
      <email>sunhao68@sina.com</email>
    </contact>
    <investigator>
      <last_name>Hao Sun, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miao He, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhengqiang Wei, MD</last_name>
      <phone>086-13228675636</phone>
      <email>384535713@qq.com</email>
    </contact>
    <investigator>
      <last_name>Zhengqiang Wei, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jijian Wang, MD</last_name>
      <phone>086-13908304080</phone>
      <email>Wangjj1963@163.com</email>
    </contact>
    <investigator>
      <last_name>Jijian Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of FoShan (Affiliated FoShan Hospital of Sun Yat-sen University)</name>
      <address>
        <city>Foshan</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Longqing Cheng, MM</last_name>
      <phone>18038863563</phone>
      <email>13702939022@139.com</email>
    </contact>
    <investigator>
      <last_name>Longqing Cheng, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yan-an Gao, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yat-sen University Cancer Center</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510060</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhizhong Pan, MD</last_name>
      <phone>086-13719388166</phone>
      <email>panzz@sysucc.org.cn</email>
    </contact>
    <investigator>
      <last_name>Zhizhong Pan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fulong Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincal people's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yong Li, MD</last_name>
      <phone>0086-138-2217-7479</phone>
      <email>liyong@gdph.org.cn</email>
    </contact>
    <contact_backup>
      <last_name>M.M</last_name>
    </contact_backup>
    <investigator>
      <last_name>Yong Li, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>ZeJian Lv, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Cancer Hospital &amp; Institute of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510095</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shuzhong Cui, MD</last_name>
      <phone>0086-138-0251-3800</phone>
      <email>cuishuzhong@126.com</email>
    </contact>
    <contact_backup>
      <last_name>Tianpei Guan, MD</last_name>
      <phone>0086-136-6089-5051</phone>
      <email>dr_guan@126.com</email>
    </contact_backup>
    <investigator>
      <last_name>Shuzhong Cui, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tianpei Guan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wei Wang, MD</last_name>
      <phone>0086-13922255515</phone>
      <email>ww1640@yeah.net</email>
    </contact>
    <investigator>
      <last_name>Wei Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>WenJun Xiong, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanfang Hospital of Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510515</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haijun Deng, MD</last_name>
      <phone>0086-13189096629</phone>
      <email>navyd999@163.com</email>
    </contact>
    <investigator>
      <last_name>Haijun Deng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai Sun, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chuangqi Chen, MD</last_name>
      <phone>086-13719334878</phone>
      <email>2632864588@qq.com</email>
    </contact>
    <investigator>
      <last_name>Chuangqi Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jianhui Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Six Affiliated Hospital,Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Meijin Huang, MD</last_name>
      <phone>086-13924073322</phone>
      <email>13924073322@139.com</email>
    </contact>
    <investigator>
      <last_name>Meijin Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wei Chen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JiangMen Central Hospital Affiliated JiangMen Hospital Of SUN YAT-SEN University</name>
      <address>
        <city>Jiangmen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chao Li, BD</last_name>
      <phone>13902888981</phone>
      <email>Lichao8981@163.com</email>
    </contact>
    <investigator>
      <last_name>Chao Li, BD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wenchuan Jiang, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MeiZhou People's Hospital</name>
      <address>
        <city>Meizhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zuguang Zuguang, MM</last_name>
      <phone>086-13502523063</phone>
      <email>wuzg1913@163.com</email>
    </contact>
    <investigator>
      <last_name>Zuguang Zuguang, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haijing Zeng, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Shantou Hospital of Sun Yat-sen University</name>
      <address>
        <city>Shantou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Xiaozhong Wang, MM</last_name>
      <phone>086-13809658922</phone>
      <email>103776710@qq.com</email>
    </contact>
    <investigator>
      <last_name>Xiaozhong Wang, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chufa Zheng, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shenzhen Second People's Hospital</name>
      <address>
        <city>Shenzhen</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Haitao Zhang, MM</last_name>
      <phone>13903025325</phone>
      <email>www.13903025325.@163.com</email>
    </contact>
    <investigator>
      <last_name>Haitao Zhang, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuanzhi Tang, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan City People's Hospital</name>
      <address>
        <city>Zhongshan</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yao Wang, MD</last_name>
      <phone>18826006277</phone>
      <email>tongjimc@126.com</email>
    </contact>
    <investigator>
      <last_name>Yao Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kai Li, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhuhai People's Hospital, Zhuhai hospital affiliated with Jinan University</name>
      <address>
        <city>Zhuhai</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hui Liang, BD</last_name>
      <phone>086-13702760386</phone>
      <email>zhlianghui@126.com</email>
    </contact>
    <investigator>
      <last_name>Hui Liang, BD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yaoming Huang, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>People's hospital of guangxi zhuang autonomous region</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi Zhuang Autonomous Region</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wei Mai, BS</last_name>
      <email>13977154858@139.com</email>
    </contact>
    <investigator>
      <last_name>Wei Mai, BS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lei Li, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiaotong Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Tumor Hospital of Guangxi Medical University</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi Zhuang Autonomous Region</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jiansi Chen</last_name>
    </contact>
    <investigator>
      <last_name>Jiansi Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hebei Medical University Fourth Hospital</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bin Yu, MM</last_name>
      <phone>13832329699</phone>
      <email>yubinli_68@163.com</email>
    </contact>
    <investigator>
      <last_name>Bin Yu, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhenya Zhang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Union Hospital,Tongji Medical College, Huazhong Uninersity of Science and Technolgy</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaixiong Tao, MD</last_name>
      <phone>0086-135-0715-5452</phone>
      <email>tao_kaixiong@163.com</email>
    </contact>
    <investigator>
      <last_name>Kaixiong Tao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chuanqing Wu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuhan University Renmin Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yongbin Zheng, MD</last_name>
      <phone>086-13871189698</phone>
      <email>13871189698@163.com</email>
    </contact>
    <investigator>
      <last_name>Yongbin Zheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chao Yang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongnan Hospital of Wuhan University</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Congqing Jiang, MD</last_name>
      <phone>086-18971525805</phone>
      <email>wb002554@whu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Congqing Jiang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Qun Qian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical University</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Song, MD</last_name>
      <phone>15105200058</phone>
    </contact>
    <investigator>
      <last_name>Jun Song, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Haixiao Fu, MM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>the First Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhigang Jie, MD</last_name>
      <phone>086-13707918042</phone>
      <email>jiezg123@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhigang Jie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tao Xiao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fudan University Shanghai Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guoxiang Cai, MD</last_name>
      <phone>086-18017312703</phone>
      <email>gxcai@fudan.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Guoxiang Cai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renjie Wang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West China Hospital，Sichuan University</name>
      <address>
        <city>Chendu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ziqiang Wang, MD</last_name>
      <phone>086-18980602028</phone>
      <email>wangzqzyh@163.com</email>
    </contact>
    <investigator>
      <last_name>Ziqiang Wang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Xiangbing Deng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sichuan Provincial People's Hospital</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>610072</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Minghui Pang, MD</last_name>
      <phone>0086-134-0282-1952</phone>
      <email>pangmh2000@163.com</email>
    </contact>
    <investigator>
      <last_name>Minghui Pang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Peoples' Hospital of Chengdu</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanjun Liu, MD</last_name>
      <email>365184541@qq.com</email>
    </contact>
    <investigator>
      <last_name>Yanjun Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yuanchuan Zhang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>People'S Hospital of Deyang City</name>
      <address>
        <city>Deyang</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gang Mai, MD</last_name>
      <phone>086-15283831000</phone>
      <email>1026823581@qq.com</email>
    </contact>
    <investigator>
      <last_name>Gang Mai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhen Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leshan people's Hospital</name>
      <address>
        <city>Leshan</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jian Wang, BD</last_name>
      <phone>086-13808138498</phone>
      <email>Wjls1963@sina.com</email>
    </contact>
    <investigator>
      <last_name>Jian Wang, BD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated hospital of southwest medical university</name>
      <address>
        <city>Luzhou</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liang Xu, MM</last_name>
      <phone>086-13708289307</phone>
      <email>XUL1104@163.com</email>
    </contact>
    <investigator>
      <last_name>Liang Xu, MM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hui Yao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital，Zhejiang University School of Medicine</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kefeng Ding, MD</last_name>
      <phone>086-13906504783</phone>
      <email>dingkefeng@zju.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Kefeng Ding, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lifeng Sun, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2020</study_first_posted>
  <last_update_submitted>June 15, 2020</last_update_submitted>
  <last_update_submitted_qc>June 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer</keyword>
  <keyword>Colectomy</keyword>
  <keyword>Hyperthermic intraperitoneal chemotherapy</keyword>
  <keyword>Peritoneal carcinomatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Peritoneal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

